Adiponectin is shown to be protective against fatty liver disease and a low circulating adiponectin has been observed in patients with chronic hepatitis and liver steatosis; inverse quantitative correlation between circulating adiponectin and grade of hepatic steatosis has been found. This evidence concerns the gene ADIPOQ and Hepatic steatosis.